Venatorx Pharmaceuticals: Funding, Investors & Team (Oct 2026)
VenatoRx is a private pharmaceutical company focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant bacterial infections and hard-to-treat viral infections. Founded in 2010, VenatoRx has built a world-class in-house R&D organization that has filed over 100 patents spanning multiple research programs. It has received significant funding awards from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH); Wellcome Trust; the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Service (HHS); the U.S. Department of Defense’s Defense Threat Reduction Agency (DTRA); and CARB-X, and as well as private equity investments from Versant Ventures, Abingworth, and Foresite Capital.
Venatorx Pharmaceuticals has raised $11.7M across 2 funding rounds on record, the most recent an undisclosed round of $11.7M announced in Sep 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Venatorx Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Venatorx Pharmaceuticals Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Venatorx Pharmaceuticals announced a Series C in Apr 2022; the amount was not disclosed.
5 months later, an undisclosed round of $11.7M was announced in Sep 2022.
Venatorx Pharmaceuticals Founders and Leadership Team
Contact details for the Venatorx Pharmaceuticals team: 2 of 2 have an email address on file.
Start 14-day free trial →Venatorx Pharmaceuticals Funding Compared to Other Biotechnology Startups
Venatorx Pharmaceuticals' latest round of $11.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Venatorx Pharmaceuticals in Biotechnology and Malvern
Companies Similar to Venatorx Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Venatorx Pharmaceuticals Funding FAQs
What does Venatorx Pharmaceuticals do?
VenatoRx is a private pharmaceutical company focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant bacterial infections and hard-to-treat viral infections. Founded in 2010, VenatoRx has built a world-class in-house R&D organization that has filed over 100 patents spanning multiple research programs. It has received significant funding awards from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH); Wellcome Trust; the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Service (HHS); the U.S. Department of Defense’s Defense Threat Reduction Agency (DTRA); and CARB-X, and as well as private equity investments from Versant Ventures, Abingworth, and Foresite Capital.
How much funding has Venatorx Pharmaceuticals raised?
Venatorx Pharmaceuticals has raised $11.7M across 2 rounds on record. The most recent is an undisclosed round of $11.7M announced in Sep 2022.
When did Venatorx Pharmaceuticals last raise funding?
Venatorx Pharmaceuticals' most recent funding round on record is an undisclosed round of $11.7M, announced in Sep 2022.
Who founded Venatorx Pharmaceuticals?
FundedIQ lists Luigi Xerri (Founder) at Venatorx Pharmaceuticals.
Who is the CEO of Venatorx Pharmaceuticals?
Christopher Burns is listed as CEO at Venatorx Pharmaceuticals.
Where is Venatorx Pharmaceuticals headquartered?
Venatorx Pharmaceuticals is based in Malvern, Pennsylvania, United States.
How many employees does Venatorx Pharmaceuticals have?
Venatorx Pharmaceuticals is in the 51-100 employee band.
How does Venatorx Pharmaceuticals' funding compare to other Biotechnology startups?
Venatorx Pharmaceuticals' latest round of $11.7M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Venatorx Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Venatorx Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.